Clostridium difficile-associated enteric disease after percutaneous endoscopic gastrostomy.
BACKGROUND
Percutaneous endoscopic gastrostomy (PEG) has become established as a useful enteral nutrition technique. Although various adverse events related to PEG are known, few reports have described Clostridium difficile-associated enteric disease (CDED) after PEG. We encountered several cases of CDED with onset soon after PEG. The present study examined these cases in detail and analyzed potential risk factors.


METHODS
A total of 239 patients underwent PEG at our hospital from 1999, and the subjects comprised 233 patients for whom data could be statistically analyzed. CDED with onset soon after PEG was defined for cases with symptoms within 1 month after PEG. We investigated features and prognosis of these cases. A total of 19 predictors were chosen, and logistic regression analysis was performed using CDED with onset soon after PEG as a dependent variable.


RESULTS
Mean patient age was high, and about 65% were men. Their body weights were low and their general condition was markedly poor. CDED with onset soon after PEG was shown in 15 patients (6.4%). Although oral administration of vancomycin resulted in prompt recovery in most cases, enteral nutrition was interrupted for a long period, and the general condition deteriorated markedly in two patients. Logistic regression analysis identified "past history of CDED" and "antibiotic dosing period at PEG" as risk factors for CDED onset soon after PEG.


CONCLUSIONS
CDED occurred with onset soon after PEG at a comparatively high rate. Our analysis suggested "past history of CDED" and "antibiotic dosing period at PEG" as risk factors for CDED after PEG.
Yokohama
Shiro
S
Department of Gastroenterology, Asahikawa Rehabilitation Hospital, 1-1 Midorigaoka Higashi, Asahikawa 078-8801, Japan.
Aoshima
Masaru
M
Asama
Toshiyuki
T
Shindo
Junya
J
Maruyama
Junichi
J
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000900:Anti-Bacterial Agents / Q000008:administration & dosage; D016360:Clostridioides difficile; D015331:Cohort Studies; D004724:Endoscopy / Q000009:adverse effects*; D004750:Enteral Nutrition; D004761:Enterocolitis, Pseudomembranous / Q000175:diagnosis / Q000209:etiology* / Q000628:therapy; D005260:Female; D005774:Gastrostomy / Q000009:adverse effects*; D006801:Humans; D008297:Male; D008875:Middle Aged; D012189:Retrospective Studies; D012307:Risk Factors; D013997:Time Factors
D000900:Anti-Bacterial Agents